Search

Your search keyword '"Plasmodium falciparum metabolism"' showing total 3,555 results

Search Constraints

Start Over You searched for: Descriptor "Plasmodium falciparum metabolism" Remove constraint Descriptor: "Plasmodium falciparum metabolism"
3,555 results on '"Plasmodium falciparum metabolism"'

Search Results

151. Differentiation of Plasmodium male gametocytes is initiated by the recruitment of a chromatin remodeler to a male-specific cis-element.

152. The Plasmodium falciparum apicoplast cysteine desulfurase provides sulfur for both iron-sulfur cluster assembly and tRNA modification.

153. The Role of Spermidine and Its Key Metabolites in Important, Pathogenic Human Viruses and in Parasitic Infections Caused by Plasmodium falciparum and Trypanosoma brucei .

154. Plasmodium falciparum has evolved multiple mechanisms to hijack human immunoglobulin M.

155. Human granzyme B binds Plasmodium falciparum Hsp70-x and mediates antiplasmodial activity in vitro.

156. Activation of the Plasmodium Egress Effector Subtilisin-Like Protease 1 Is Mediated by Plasmepsin X Destruction of the Prodomain.

157. The human malaria parasite Plasmodium falciparum can sense environmental changes and respond by antigenic switching.

158. miR-34c-3p Regulates Protein Kinase A Activity Independent of cAMP by Dicing prkar2b Transcripts in Theileria annulata-Infected Leukocytes.

159. Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion.

160. Changes in K + Concentration as a Signaling Mechanism in the Apicomplexa Parasites Plasmodium and Toxoplasma .

161. Sulfonylpiperazine compounds prevent Plasmodium falciparum invasion of red blood cells through interference with actin-1/profilin dynamics.

162. A genome-wide map of DNA replication at single-molecule resolution in the malaria parasite Plasmodium falciparum.

163. A Chimeric Peptide Inhibits Red Blood Cell Invasion by Plasmodium falciparum with Hundredfold Increased Efficacy.

164. Analysis of genome instability and implications for the consequent phenotype in Plasmodium falciparum containing mutated MSH2-1 (P513T).

165. Bioguided Fractionation and Isolation of an Antiplasmodial Saponin from the Roots of Nauclea xanthoxylon (A.Chev.) Aubrév. (Rubiaceae).

166. Ring stage dormancy of Plasmodium falciparum tolerant to artemisinin and its analogues - A genetically regulated "Sleeping Beauty".

167. Formation of ER-lumenal intermediates during export of Plasmodium proteins containing transmembrane-like hydrophobic sequences.

168. Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1.

169. Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation.

170. Fast-Killing Tyrosine Amide (( S )-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus ( Pf CARL).

171. Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target.

172. Structures of Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) Isoforms and Their Interactions with Chloroquine.

173. Structure and function of Plasmodium actin II in the parasite mosquito stages.

174. Plasmodium DDI1 is a potential therapeutic target and important chromatin-associated protein.

175. Identification of natural products against enoyl-acyl-carrier-protein reductase in malaria via combined pharmacophore modeling, molecular docking and simulations studies.

176. What make malarial adenosine deaminase from PLASMODIUM VIVAX recognise adenosine and 5'-methylthioadenosine: simulation studies.

177. A Microtubule-Associated Protein Is Essential for Malaria Parasite Transmission.

178. Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents.

179. Patterns of Heterochromatin Transitions Linked to Changes in the Expression of Plasmodium falciparum Clonally Variant Genes.

180. New insights into apicoplast metabolism in blood-stage malaria parasites.

181. Structural characterization of glutamyl-tRNA synthetase (GluRS) from Plasmodium falciparum.

182. Disulfide bond and crosslinking analyses reveal inter-domain interactions that contribute to the rigidity of placental malaria VAR2CSA structure and formation of CSA binding channel.

183. Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II.

184. A Plasmodium falciparum ubiquitin-specific protease (PfUSP) is essential for parasite survival and its disruption enhances artemisinin efficacy.

185. Protein KIC5 is a novel regulator of artemisinin stress response in the malaria parasite Plasmodium falciparum.

186. The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway.

187. An in silico quest for next-generation antimalarial drugs by targeting Plasmodium falciparum hexose transporter protein: a multi-pronged approach.

188. Histone lactylation: a new epigenetic axis for host-parasite signalling in malaria?

189. Quantifying pH in Malaria Using pHluorin and Flow Cytometry.

190. Characterisation of PfCZIF1 and PfCZIF2 in Plasmodium falciparum asexual stages.

191. Molecular docking and antimalarial evaluation of hybrid para -aminobenzoic acid 1,3,5 triazine derivatives via inhibition of Pf -DHFR.

192. Structural insights into acetylated histone ligand recognition by the BDP1 bromodomain of Plasmodium falciparum.

193. Novel 3-Trifluoromethyl-1,2,4-oxadiazole Analogues of Astemizole with Multi-stage Antiplasmodium Activity and In Vivo Efficacy in a Plasmodium berghei Mouse Malaria Infection Model.

194. Leveraging a Fluorescent Fatty Acid Probe to Discover Cell-Permeable Inhibitors of Plasmodium falciparum Glycerolipid Biosynthesis.

195. Surveillance of pfhrp2 and pfhrp3 gene deletions among symptomatic Plasmodium falciparum malaria patients in Central Vietnam.

196. Detection of histidine-rich protein 2- and/or 3-deleted Plasmodium falciparum using the automated hematology analyzer XN-31: A proof-of-concept study.

197. Analysis of Plasmodium falciparum myosin B ATPase activity and structure in complex with the calmodulin-like domain of its light chain MLC-B.

198. Physiological jump in erythrocyte redox potential during Plasmodium falciparum development occurs independent of the sickle cell trait.

199. Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.

200. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.

Catalog

Books, media, physical & digital resources